Non-steroidal anti-inflammatory drugs, glucocorticoids and other immunosuppressants, that are commonly used in the treatment of RA, inhibit the NF-κB pathway and the expression of different inflammatory-associated genes. Here, NFKB1 is linked to rheumatoid arthritis.